Plain-English translation of NCT05564793 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a device called Amycard 01C can help doctors place your heart pacemaker (CRT device) in a better location. The device creates a detailed electrical map of your heart before surgery, which may help your new pacemaker work more effectively. You'll be randomly assigned to either receive this mapping guidance before surgery, or to have surgery the usual way.
Current pacemaker placement relies on the surgeon's experience and what's available during the procedure. Researchers believe that using detailed heart mapping beforehand could help doctors find the optimal placement location, potentially improving how well the pacemaker helps your heart function.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly placed in one of two groups. Both groups will receive a pacemaker implant and have heart function checked with ultrasound. The main difference is that one group will have detailed heart electrical mapping done before surgery to guide lead placement, while the other group will have the standard procedure. You'll complete quality-of-life questionnaires, have an ECG mapping procedure (which involves placing sticky patches on your chest and a CT scan), and return for a 6-month follow-up visit to check how well the pacemaker is working.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Netherlands